Business Description
Lonza Group Ltd
SIC : 2836
ISIN : CH0013841017
Share Class Description:
FRA:LO3: Ordinary SharesTotal Employee Number:
19,771Compare
Compare
Traded in other countries / regions
LONN.Switzerland0QNO.UKLZAGY.USALON.Canada1LONN.ItalyLO3A.GermanyLONNN.MexicoO6Z.Singapore Description
Lonza Group Ltd is a Swiss contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotech, and nutrition industries. It operates through segments including Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients, providing services spanning drug development, clinical supply, and commercial manufacturing. Its offerings cover mammalian and microbial biologics, antibody-drug conjugates, small-molecule APIs, cell and gene therapies, and capsule and dosage-form solutions. Customers include pharmaceutical and biotechnology companies, academic institutions, and government research organizations worldwide. Lonza generates revenue primarily through long-term supply agreements and fee-for-service contracts tied to the product lifecycle, from research through commercial supply. The company operates manufacturing and research facilities across Europe, North America, and Asia, with headquarters in Basel, Switzerland.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.51 | |||||
Debt-to-EBITDA | 2.75 | |||||
Interest Coverage | 10.22 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.59 | |||||
Beneish M-Score | -3.16 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.6 | |||||
3-Year EBITDA Growth Rate | 1.4 | |||||
3-Year EPS without NRI Growth Rate | 0.7 | |||||
3-Year FCF Growth Rate | 35.4 | |||||
3-Year Book Growth Rate | -7.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 19.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.99 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.56 | |||||
9-Day RSI | 46.35 | |||||
14-Day RSI | 44.4 | |||||
3-1 Month Momentum % | 12.63 | |||||
6-1 Month Momentum % | 11.13 | |||||
12-1 Month Momentum % | 2.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.66 | |||||
Quick Ratio | 1.21 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 150.81 | |||||
Days Sales Outstanding | 84.76 | |||||
Days Payable | 41.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.94 | |||||
Dividend Payout Ratio | 0.29 | |||||
3-Year Dividend Growth Rate | 10.1 | |||||
Forward Dividend Yield % | 0.94 | |||||
5-Year Yield-on-Cost % | 1.42 | |||||
3-Year Average Share Buyback Ratio | 2 | |||||
Shareholder Yield % | 2.81 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.56 | |||||
Operating Margin % | 22.91 | |||||
Net Margin % | -1.6 | |||||
EBITDA Margin % | 22.06 | |||||
FCF Margin % | 3.35 | |||||
OCF Margin % | 22.83 | |||||
ROE % | -1.34 | |||||
ROA % | -0.6 | |||||
ROIC % | 7.48 | |||||
3-Year ROIIC % | -1.06 | |||||
ROC (Joel Greenblatt) % | 13.88 | |||||
ROCE % | 10.05 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 25.08 | |||||
PE Ratio without NRI | 32.21 | |||||
Shiller PE Ratio | 44.79 | |||||
PEG Ratio | 4.6 | |||||
PS Ratio | 5.63 | |||||
PB Ratio | 4.75 | |||||
Price-to-Tangible-Book | 6.61 | |||||
Price-to-Free-Cash-Flow | 249.36 | |||||
Price-to-Operating-Cash-Flow | 26.94 | |||||
EV-to-EBIT | 28.29 | |||||
EV-to-Forward-EBIT | 21.39 | |||||
EV-to-EBITDA | 27.52 | |||||
EV-to-Forward-EBITDA | 15.88 | |||||
EV-to-Revenue | 6.07 | |||||
EV-to-Forward-Revenue | 5.14 | |||||
EV-to-FCF | 263.31 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 9.41 | |||||
Price-to-Median-PS-Value | 1.02 | |||||
Price-to-Peter-Lynch-Fair-Value | 5.24 | |||||
Price-to-Graham-Number | 3.08 | |||||
Earnings Yield (Greenblatt) % | 3.54 | |||||
FCF Yield % | 0.42 | |||||
Forward Rate of Return (Yacktman) % | 6.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lonza Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 6,843.998 | ||
| EPS (TTM) (€) | -1.516 | ||
| Beta | 0.2764 | ||
| 3-Year Sharpe Ratio | 0.54 | ||
| 3-Year Sortino Ratio | 4.5 | ||
| Volatility % | 19.3 | ||
| 14-Day RSI | 44.4 | ||
| 14-Day ATR (€) | 7.570515 | ||
| 20-Day SMA (€) | 596.85 | ||
| 12-1 Month Momentum % | 2.77 | ||
| 52-Week Range (€) | 500.4 - 641 | ||
| Shares Outstanding (Mil) | 69.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lonza Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lonza Group Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-01-28 14:00 | In 129 days | ||
| Fourth quarter earnings results for 2026 | 2027-01-28 | In 128 days | ||
| Citi HC Conference, Miami (United States) | 2026-12-01 | In 70 days | ||
| Berenberg Roadshows and Conferences | 2026-11-26 | In 65 days | ||
| Kepler Cheuvreux Equity Day, Geneva (Switzerland) | 2026-11-24 | In 63 days | ||
| Jefferies HC Conference, London (United Kingdom) | 2026-11-17 | In 56 days | ||
| ZKB Swiss Equity Conference, Zurich (Switzerland) | 2026-11-05 | In 44 days | ||
| Guidance call for 2026 | 2026-10-14 09:00 | In 23 days | ||
| UBS Swiss Equity Conference | 2026-09-22 | 582.00 (+1.32%) | ||
| Morgan Stanley HC Conference, New York (United States) | 2026-09-15 | 573.00 (+2.54%) |
Show
Entries
Lonza Group Ltd Frequently Asked Questions
What is Lonza Group Ltd(FRA:LO3)'s stock price today?
The current price of FRA:LO3 is €583.60. The 52 week high of FRA:LO3 is €641.00 and 52 week low is €500.40.
When is next earnings date of Lonza Group Ltd(FRA:LO3)?
The next earnings date of Lonza Group Ltd(FRA:LO3) is 2027-01-28 Est..
Does Lonza Group Ltd(FRA:LO3) pay dividends? If so, how much?
The Dividend Yield %  of Lonza Group Ltd(FRA:LO3) is 0.94% (As of Today), Highest Dividend Payout Ratio of Lonza Group Ltd(FRA:LO3) was 0.31. The lowest was 0.2. And the median was 0.27. The  Forward Dividend Yield % of Lonza Group Ltd(FRA:LO3) is 0.94%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers